Mass deaths warning: bird flu spread set to accelerate
An accelerating bird flu outbreak could materially affect poultry and egg supply through higher mortality and culling risk.
Source →The trace
How it reaches your house.
Starting from Poultry Biosecurity Inputs & HPAI Vaccines, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Chicken and turkey →Shortage riskGrow-Out (Contract Grower Farm)
Reduced placements and flock losses cut grow-out volume for contract farms.
71% confidenceChicken and turkey →Shortage riskHatchery & Day-Old Chick Placement
Fewer healthy eggs/chicks and movement controls reduce hatchery throughput and placements.
70% confidenceChicken and turkey →DelaysLive Haul & Ante-Mortem Inspection
Quarantine, culling, and tighter biosecurity can slow live-haul movements and inspection workflows.
68% confidencePoultry Biosecurity Inputs & HPAI Vaccines →Stands to benefitHop 2
Boehringer Ingelheim Animal Health →Prices risePoultry Biosecurity Inputs & HPAI Vaccines
Accelerating bird flu should lift demand for poultry biosecurity inputs and HPAI vaccines, and Boehringer Ingelheim's 25% share plus 24-month replacement lead time make that input market prone to tighter supply and higher prices.
82% confidenceMerck Animal Health (MSD Animal Health) →Prices risePoultry Biosecurity Inputs & HPAI Vaccines
An accelerating HPAI outbreak should raise demand for poultry biosecurity inputs and vaccines, and Merck has a 15% share in this category with a 12-month replacement lead time, so prices are likely to rise.
76% confidenceCeva Santé Animale →Shortage risk